Shanshan Feng

Shanshan Feng currently serves as the Associate Director and Project Leader of IND-enabling Studies at WuXi Biologics since June 2022. Prior to this role, Shanshan was a Project Manager of Toxicology at HEC Pharm Co., Ltd. from September 2018 to June 2022 and worked as a Research Scientist at CapitalBio Corporation from July 2017 to September 2018. Shanshan holds a doctorate in Biochemistry and Molecular Biology from the University of Chinese Academy of Sciences, completed in June 2017, and also participated in an exchange program at the University of Nebraska Medical Center in 2012. Shanshan obtained a bachelor's degree in the Biological Sciences from Wuhan University in June 2009.